IsoFlow Infusion Catheter System

Vascular Designs has secured 510(k) marketing clearance by the U.S. Food and Drug Administration (FDA) for its IsoFlow™ catheter device which enables the direct delivery of medications into highly targeted areas. An important application of IsoFlow may be in the treatment of cancer.

IsoFlow enables sideways perfusion, which allows physicians to precisely target and isolate areas within the body where the infused fluids are delivered. With IsoFlow’s unique design, medications can be pushed sideways into areas which physicians were previously unable to treat directly using pressure.

According to numerous studies, a direct delivery approach can help physicians increase drug concentrations at targeted sites while reducing systemic exposure, thereby improving efficacy and patient outcomes, such as when treating cancerous tumors with chemotherapy.